Bristol-Myers Squibb Company And Corgentech, Inc. Drug Not Effective In Preventing Bypass Vein Clogging

DALLAS-- A new drug, edifoligide, designed to prevent the clogging of veins used in coronary bypass surgery was no more effective than a placebo, according to the results of a Phase III clinical trial led by researchers at Duke Clinical Research Institute (DCRI).